Overall, our study provides novel evidence regarding the angiocrine action elicited by IGF1 in breast cancer through the activation of HIF-1α/VEGF signaling pathway, emphasizing the important role played by GPER in the modulation of this relevant transduction axis. The gene discussed is VEGFA; the disease is breast carcinoma.